Skip to main content
Premium Trial:

Request an Annual Quote

GPC Forms US Subsidiary, Recruits Two Executives

Premium

MUNICH--GPC, a second-generation genomics-based drug discovery company, has created a US subsidiary, GPC USA, based in Princeton, NJ. John Richard has been named US business development advisor and Gregory Hamm is vice-president of bioinformatics and US site head.

Richard's background includes developing strategic alliances in genomics, drug discovery, and drug delivery. He has been executive vice-

president at Sequus Pharmaceuticals and head of business development at Vivus and at Genome Therapeutics.

Hamm was previously vice-president of bioinformatics at Genome Therapeutics, where he took part in the development and management of several of the company's pharmaceutical alliances, including its first drug-discovery database product. Hamm has been director of the Molecular Biology Computing Laboratory at Rutgers University, principal consultant at Systems & Bioinformatics, and head of computing at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Hamm is also the founder of the EMBL Data Library.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.